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ABSTRACT
Objective: In the last few years the genetic influence
on health and disease outcome has become more
apparent. The ACE genotype appears to play a
significant role in the pathophysiology of several
disease processes. This pilot study aims at showing
the feasibility to examine the genetic influence of the
ACE genotype on return of spontaneous circulation
(ROSC) in out-of-hospital cardiac arrest (OHCA).
Methods: We performed a prospective observational
study of all OHCAs of presumed cardiac origin in a
well-defined population. We collected prehospital blood
samples for the determination of ACE genotype and
used this information together with Utstein template
parameters in a multivariable analysis to examine the
relationship between ROSC and ACE genotype.
Results: We collect blood samples in 156 of 361
patients with OHCA of presumed cardiac origin, 127
samples were analysed (mean age 67 years, 86% male,
79% witnessed OHCA, 80% bystander CPR, 62% had
a shockable rhythm, ROSC 77%). Distribution of the
ACE gene polymorphisms: insertion polymorphism (II)
n=22, 17%, insertion/deletion polymorphism (ID)
n=66, 52% and deletion polymorphism (DD) n=39,
31%. We found no significant association between ACE
II vs ACE DD/DI and ROSC (OR 1.72; CI 0.52 to 5.73;
p=0.38). Other ACE genotype groupings (II/ID vs DD or
II vs DD) did not change the overall finding of lack of
impact of ACE genotype on ROSC.
Conclusions: This pilot study did not indicate a
significant association between ACE gene
polymorphism and ROSC. However, it has
demonstrated that prehospital genetic studies including
blood sampling are feasible and ethically acceptable.
INTRODUCTION
Despite more than 1000 cases of out-of-hospital
sudden cardiac arrest (OHCA) occurring
throughout Europe every day, neurologically
intact survival remains poor; currently no more
than 10–25% in the best emergency medical
systems (EMS).1 2 Even when the entire chain
of survival is working efﬁciently and effectively,
outcome is difﬁcult to predict, reﬂecting the
many factors, both known and unknown, that
contribute to overall survival. While many
important predictors for survival are under-
stood, such as an initial shockable rhythm, a
witnessed arrest and bystander cardiopulmon-
ary resuscitation (CPR), many other more
subtle predictors are likely to be in play.3
In many areas of medicine, the genetic
inﬂuence on health, disease progression and
response to therapy is becoming apparent.
The understanding of genetic-based altera-
tions and diseases of the human body has
expanded enormously during the past
20 years.4 Several correlations between
genetic polymorphism and increased risk for
disease development and outcome have
KEY MESSAGES
What is already known about this subject?
▸ We know the significant effects of angiotensin
converting enzyme (ACE) genotype on survival
from critical illness and major trauma. The ACE
genotype is contributing to vascular tone and
therefore we decided to perform a pilot study of
the relationship between ACE genotype and
return of spontaneous circulation in patients
with out of hospital cardiac arrest.
What does this study add?
▸ This pilot study has demonstrated the feasibility
of collecting blood samples from out of hospital
cardiac arrest patients even if not admitted to
the receiving hospital later and showed how
practical, legal and ethical challenges might be
overcome in such pre-hospital studies.
How might this impact on clinical practice?
▸ More knowledge on the genetic influence on
return of spontaneous circulation rate may affect
how we treat such out-of-hospital cardiac arrest
patients and lead to improved prognosis.
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since been established and it is likely that a genetic com-
ponent determines response to some of the many patho-
physiological pathways at play during attempted
resuscitation from OHCA.5
An important determinant of return of spontaneous cir-
culation (ROSC) during resuscitation from OHCA is the
diastolic blood pressure generated during external cardiac
chest compressions; this determining the subsequent cor-
onary perfusion pressure.6
Vascular tone is a major factor determining diastolic
blood pressure during CPR and is known to be inﬂu-
enced by genetic polymorphism of the angiotensin con-
verting enzyme (ACE) gene.6–8 The peptide hormone
angiotensin II (AGII) is part of the renin–angiotensin–
aldosterone system which controls blood pressure regula-
tion. AGII acts to constrict vascular smooth muscle
resulting in increased vascular tone and therefore
increased blood pressure. The ACE gene has three geno-
types: insertion polymorphism (II); insertion/deletion
polymorphism (ID) and deletion polymorphism (DD).
The absence (deletion, D) rather than the presence
(insertion, I) of a 287 base pair fragment in the ACE
gene is associated with higher circulating and tissue ACE
activity.7 8 This genetic effect accounts for 47% of the
total variance of serum ACE.7
The ACE genotype appears to play a signiﬁcant role in
the pathophysiology of several disease processes,
although the exact mechanisms are poorly understood.
In patients with the DD/DI genotype, excess mortality
has been shown in adult acute respiratory distress syn-
drome 9 and paediatric meningococcal infection10 and
the genotype has also been linked to trauma survival
and worse functional outcome from traumatic brain
injury.11 12
In view of the signiﬁcant effects on ACE genotype on
survival from critical illness and major trauma and the
role of the ACE genotype in determining vascular tone,
we decided to perform a pilot study of the relationship
between ACE genotype and outcome from OHCA of
presumed cardiac cause. We felt such a pilot study focus-
ing on feasibility could generate valuable information
for future genetic OHCA studies independent of its
ﬁndings. Hence, we established a study protocol with
ethical approval, which made it possible to collect blood
samples from OHCA victims with ongoing resuscitation
or return of spontaneous circulation, to analyse the ACE
genotype in OHCA victims in Western Norway.
METHODS
Study design
We performed a prospective observational study of all
patients suffering OHCA in the Stavanger region of
Norway; an area with a primarily Caucasian population
of about 320 000.13 During the study period (February
2007—November 2010), the EMS responded to 787
emergency calls to patients with OHCA, of which a
presumed cardiac origin, according to the Utstein deﬁ-
nitions,14 15 was found in 361 patients (ﬁgure 1).
System overview
All OHCA patients with ROSC in the study region are
transported to one hospital—the Stavanger University
Hospital. The dispatch and EMS from the study area has
been described previously.2 16 In summary, a single
alarm and dispatch centre is responsible for all call-outs
of ambulance units, including a physician-manned unit,
either by air or road. The alarm and dispatch centre
also advises bystanders in CPR, including mouth-to-
mouth ventilation. System outcome data has recently
been published.2
Clinical care
During the study period, all patients suffering OHCA
and recruited to the study received advanced life
support from the ambulance crew. In addition to the
paramedic crew, a doctor was dispatched to all cases of
OHCA. The 2005 European Resuscitation Council
(ERC) resuscitation guidelines with Norwegian altera-
tions were in use for all patients in this study.17
Termination of CPR mostly occurred on scene and
was decided by an attending medical professional
(general practitioner on call or physician-manned rapid
response unit) according to local protocol.2 A minority
of patients were admitted to hospital with ongoing CPR
and subsequently entered into the appropriate group,
depending on whether ROSC was achieved in the emer-
gency department.
Ethical considerations
All EMS paramedics who participated in the blood
sample collection process received teaching in technical
and ethical aspects of the study. The study and the use
Figure 1 Flow chart of 787 patients with out-of-hospital
cardiac arrest between February 2007 and November 2010
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of local databases were approved by the Norwegian
Social Science Data Service, the Regional Committee for
Research Ethics and the local EMS. The Regional
Committee for Research Ethics accepted that no
informed consent could be obtained before blood sam-
pling from the patient or from the next-of-kin.
Therefore, informed consent was obtained retrospect-
ively, either from the patients directly if they regained
the ability to consent after the treatment for their
OHCA or from the next-of-kin in cases where the
patient did not survive or did not make sufﬁcient neuro-
logical recovery to give informed consent. If informed
consent from next-of-kin was necessary this was obtained
several weeks after the OHCA event to allow next-of-kin
to recover from their severe loss. Oral and written infor-
mation was given by the investigators to those giving
consent and signed approval was obtained.
Cardiac arrest registry
All patients treated for OHCA by the EMS routinely
have their details entered into the hospital-owned
Utstein-based database. For this study the Utstein-
based14 15 database was accessed for all included patients
to extract the OHCA data for further analysis. Origin of
the OHCA was determined prehospital following the
Utstein recommendations.14 15 For quality assurance,
data were crossed-checked before being entered in the
study database. Missing data for each performed analysis
are noted in the Results section
Collection of genetic material
The collection of blood samples was performed by the
EMS paramedics without either disturbing or delaying
the standard CPR protocol. Samples were either drawn
on scene or in patients with ROSC, following transport
to the hospital. Most of the blood samples were there-
fore obtained either after establishing ROSC or once
CPR efforts were terminated. If the resuscitation efforts
were terminated on scene, the deceased was, according
to local law, no longer in the sphere of responsibility of
the EMS. Therefore, no blood samples could be col-
lected after death was declared by the on-scene phys-
ician. In order to improve recruitment, 10 additional
blood samples were collected in the Bergen region,
which have a similar EMS physician-manned service.18 19
Blood was drawn from an intravenous cannula in a
peripheral vein, either from a cannula prior to adminis-
tration of drugs or ﬂuids, or from a separate unused
intravenous cannula. Up to 20 mL venous blood was
withdrawn into two 10 mL glass tubes coated with EDTA.
These samples were transferred to the hospital, either
together with the patient or by the EMS alone and,
without further processing, stored at −80°C. The genetic
analysis was performed as a single batch after all samples
had been obtained.
Genetic analysis
Genomic DNA from 1 mL of whole blood was extracted
using Qiagen Genomic-tip 20/G (QIAGEN AB;
SE-19124 Sollentuna) according to manufacturer’s
instructions.20 The eluted DNA was precipitated and dis-
solved. The ACE polymorphism analysis was determined
using PCR under standard conditions described else-
where.21 One microliter of the PCR reaction product is
analysed by capillary electrophoresis using a
microﬂuidics-based platform for sizing, quantiﬁcation
and quality control of DNA (Agilent 2100 Bioanalyzer)
to separate the 191 bp-long D variant from the
478 bp-long I variant.
Statistical analysis
Data were entered into a FilemakerPro7 database
(FileMaker, Inc; USA), and SPSS V.20.0 (SPSS, Inc;
USA) was used for statistical analysis. Figures were con-
structed using MicrosoftOfﬁce 2010 (Microsoft
Corporation, USA). A χ2 test was used to examine differ-
ences in proportions for categorical variables. Student
t test and analysis of variance were used to examine
between-group differences for continuous variables.
A multiple logistic regression model was constructed.
Goodness of ﬁt for the logistic regression model was veri-
ﬁed by the Hosmer-Lemeshow test.
Two-sided p values <0.05 were considered statistically
signiﬁcant. Missing data occurred in several variables
examined in this study. Information on the missing data
is shown in the tables if the missing data comprised
more than 5% of all data collected for the variable. The
numbers of complete data sets are reported for the mul-
tivariable analyses.
The presentation of the three ACE gene polymorph-
isms were carried out separately, but also aggregated in
two groups; ACE II against ACE DD/ID as described by
Kehoe.12
RESULTS
Of the 361 patients with an OHCA of presumed cardiac
origin, 156 had blood samples drawn (ﬁgure 1). A total
of 127 blood samples were eligible for genetic poly-
morphism analysis, while a further 29 blood samples
were not analysed due to lack of informed consent.
Table 1 shows the demographic and clinical character-
istics of the study population and the univariate analysis
of factors linked to ROSC, which was achieved in 59% of
the studied patients.
Table 2 shows the demographic and clinical character-
istics of the study population stratiﬁed by the ACE geno-
type groups II against ID+DD, while table 3 presents the
association between ACE genotype and ROSC, adjusted
for demographic and clinical factors. The univariate
analysis indicated a possible association between ROSC
rate and ACE gene polymorphism (table 2; p=0.15).
However, we did not ﬁnd a signiﬁcant relationship
between ACE genotype and ROSC in the multivariable
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analysis (table 3). Comparing other ACE genotype
groupings (II/ID vs DD or II vs DD) did not change the
overall ﬁnding of lack of impact of ACE genotype on
ROSC.
DISCUSSION
The aim of our pilot study was to show the feasibility to
examine the genetic inﬂuence between ACE genotype
and ROSC in OHCA of presumed cardiac origin. We
could not demonstrate such a relationship between ACE
genotype and ROSC in OHCA victims. Had the
association of ACE genotype with ROSC been as strong
as that reported with survival from major trauma,12 we
would have expected to see a signiﬁcant association
despite the relatively small number of patients studied.
Although probably related to mechanisms other than
vascular tone, ACE gene polymorphism has also shown a
strong association in other diseases where it determines
variations in acute lung injury in sepsis,22 23 impaired
lung function9 and recovery from traumatic brain
injury.11 In western Caucasian population such as ours,
the distribution of the ACE genotype is expected to be
II 25%, ID 50% and DD 25%.24–27 This is similar to the
Table 1 Demographic characteristics of the study population for the ‘ROSC’ and ‘No ROSC’ groups
All patients
n=127
ROSC
n=75
No ROSC
n=52 p Value
Age, year, mean (SD) 67 (15) 65 (14) 70 (15) 0.042
Male sex, n (%) 109 (86) 66 (88) 43 (83) 0.399
Witnessed OHCA, n (%) 100 (79) 65 (87) 35 (67) 0.014
Bystander CPR, n (%) 102 (80) 63 (84) 39 (75) 0.210
Location OHCA home, n (%) md=31 63 (50) 31 (41) 32 (62) 0.436
EMS response time in minutes; mean (SD) 9 (6) 8 (5) 11 (6) 0.019
First rhythm shockable, n (%) 79 (62) 58 (77) 21 (40) <0.001
ACE II, n (%) 22 (17) 16 (21) 6 (12) 0.151
ACE ID, n (%) 66 (52) 37 (49) 29 (55) 0.765
ACE DD, n (%) 39 (31) 22 (29) 17 (33) 0.162
DD, deletion polymorphism; II, insertion polymorphism; ID, insertion/deletion polymorphism; ROSC, return of spontaneous circulation.
Table 2 Demographic characteristics of the study population according to the ACE genotype groups II against ID+DD
All patients
n=127
ACE II
n=22, (17%)
ACE ID/DD
n=105, (83%) p Value
Age, year, mean (SD) 67 (15) 69 (18) 67(14) 0.527
Male sex, n (%) 109 (86) 21 (95) 88 (84) 0.154
Witnessed OHCA, n (%) 100 (79) 17 (77) 83 (79) 0.853
Bystander CPR, n (%) 102 (80) 19 (86) 83 (79) 0.432
Location OHCA home, n (%) md=31 63 (50) 11 (50) 52 (50) 0.946
EMS response time in minutes; Mean (SD) 9 (6) 7 (5) 10 (6) 0.092
First rhythm shockable, n (%) 79 (62) 15 (68) 64 (61) 0.525
ROSC n (%) 75 (59) 16 (73) 59 (56) 0.151
DD, deletion polymorphism; II, insertion polymorphism; ID, insertion/deletion polymorphism; ROSC, return of spontaneous circulation.
Table 3 Factors associated with ROSC in the study population (n=127)
OR 95% CI p Value
Age (one additional year) 0.98 0.95 to 1.00 0.117
Gender (female) 1.98 0.56 to 6.96 0.287
Witnessed OHCA 3.07 0.98 to 9.65 0.055
Shockable rhythm 5.28 2.03 to 13.72 0.001
EMS response time (one additional minute) 0.90 0.83 to 0.98 0.015
ACE genotype
ACE II/ACE (DD+ID) 1.72 0.52 to 5.73 0.377
Missing data 7.
ACE, angiotensin converting enzyme; DD/ID, deletion polymorphism/insertion/deletion polymorphism; II, insertion polymorphism; OHCA, out-
of-hospital cardiac arrest; ROSC, return of spontaneous circulation.
4 Lindner TW, Deakin CD, Aarsetøy H, et al. Open Heart 2014;1:e000138. doi:10.1136/openhrt-2014-000138
Open Heart
distribution found in our small patient cohort and that
of the population of trauma patients demonstrating a
strong association of ACE genotype with outcome.12
Recent ACE genotype research has failed to demon-
strate an association with outcome in several cardiac dis-
eases28 and has also demonstrated the multifactorial
nature of the control of vascular tone.29–31
ACE gene polymorphism controlling angiotensin path-
ways may only be one of several physiological mechan-
isms to inﬂuence the effect of vascular tone on
promoting adequate diastolic blood pressure to achieve
ROSC during OHCA. ACE genotype alone as a marker
of risk in disease processes may well be too simplistic an
approach to understanding the effects of genotype on
disease processes. A more targeted approach and larger
sample sizes may be appropriate for future studies.
Since the inception of this study, more speciﬁc methods
of analysing ACE genotype and associated metabolic
pathways have become available, such as measured-
haplotype analysis of single nucleotide polymorphisms23
and future studies may be better directed using these
methods.
Where genotype is associated with a speciﬁc pheno-
typic defect, rather than a subtle inﬂuence on metabolic
pathways, a clearer association with genotype is often
apparent. A number of studies have demonstrated that
sudden cardiac death has a strong genetic component,
particularly in association with structural defects and
sudden malignant arrhythmias.32 A number of other
genetic polymorphisms have all been associated with an
altered risk of coronary artery disease and myocardial
infarction which are indirect risk factors for cardiac
arrest.33 An understanding of the genetic contributions
to outcome from resuscitation could add substantially to
the prediction and management of cardiac arrest and is
a goal worth pursuing. We therefore believe that the
main value of our pilot study is to serve as a feasibility
model for future prehospital genetic studies in OHCA
victims unable to give informed consent.
With regard to our study design, we believe that the
present study has demonstrated the practical and ethical
feasibility of collecting blood samples from patients in
the prehospital arena, even if not admitted to the receiv-
ing hospital later. This design facilitates the collection of
important information from OHCA victims who were
declared dead on the scene even if no blood was drawn
after declaration of death as described by Johnson.34
The approach used in this study can be used as an
example for other studies where human material needs
to be collected. The ethical details are applicable to
other research studies in the prehospital arena. The
ethical aspects of this study were universally accepted by
EMS personal, but we found that about 20% of patients
and/or relatives later declined to give informed consent.
The main reason to decline informed consent from rela-
tives was the wish not to be reminded about the death of
the deceased and therefore the unwillingness of involve-
ment. Some patients and/or relatives were
uncontactable, thus preventing the use of these samples
and data in the study.
In summary this demonstrates that it is possible to
conduct genetic research in the ethically challenging
prehospital environment with patients unable to give
consent, but that studies must take into account a
relatively large drop-out rate. Our experience also indi-
cates that there may be a need for extra staff on
scene, responsible solely for collection of biological
specimens.
Limitations
The major limitation of this study is the small sample
size, which is of particular relevance for genetic studies
that often require sample size orders of a magnitude
much greater than was possible in our study.33 34 The
small patient cohort studied may also explain why other
factors like age and witnessed OHCA did not show sig-
niﬁcant associations with ROSC.
A main concern in the present pilot study was that the
delivery of advanced life support by EMS crews should
not be interrupted by the need to obtain a blood
sample for the study. It was only possible to collect blood
samples when enough resources were present at the
OHCA scene. Several patients could not be included
due to this limitation. Other ethical or logistical consid-
erations on scene may also have inﬂuenced the inclusion
of patients when effort was focussed on the resuscitation
attempt. This may have inﬂated the proportion of
patients with ROSC in our study cohort and thus limited
the sample size in the comparator group.
CONCLUSIONS
This pilot study of 127 OHCA victims did not demon-
strate a clear association between ACE gene polymorph-
ism and ROSC, and was limited in its interpretation by
the relatively small sample size. However, the pilot study
has demonstrated the feasibility of collecting blood
samples from patients with OHCA and demonstrates
how practical, legal and ethical challenges might be
overcome in such pre-hospital studies. More pre-hospital
genetic studies in adequately powered cohorts of OHCA
victims will help move forward the frontier of genetic
inﬂuence on resuscitation outcomes.
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